This inventor holds 6 USPTO granted patents. Top assignees: Devicor Medical Products, Inc., Ethicon Endo-Surgery, Inc.. Active years: 2003-2019.
Company Filing History:

Years Active: 2003-2019
Title: Scott A Gleason: Innovator in Surgical Biopsy Technology
Introduction
Scott A Gleason is a notable inventor based in Oshkosh, WI (US). He has made significant contributions to the field of medical technology, particularly in the development of surgical biopsy systems. With a total of 6 patents to his name, Gleason's work has advanced the capabilities of biopsy procedures.
Latest Patents
One of Gleason's latest patents involves a method for calibrating a surgical biopsy system. This innovative biopsy system includes a biopsy instrument and a control unit. The biopsy instrument is equipped with a piercer, a rotatable cutter, and a port for receiving tissue samples. The method consists of several steps, including translating the cutter distally until it reaches an extended position, recording this position, and then translating the cutter proximally to a retracted position. The retracted position is also recorded. Furthermore, the method includes rotating the cutter to a specific rotation speed while it is at the retracted position. If the rotation speed falls within a predetermined range, a feedback signal is displayed, allowing the operator to proceed to the next step in the procedure.
Career Highlights
Throughout his career, Scott A Gleason has worked with prominent companies in the medical field, including Devicor Medical Products, Inc. and Ethicon Endo-Surgery, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical devices.
Collaborations
Gleason has collaborated with several professionals in his field, including Mark A Burdorff and Daniel F Dlugos. These collaborations have likely enhanced his work and contributed to the success of his inventions.
Conclusion
Scott A Gleason is a distinguished inventor whose work in surgical biopsy technology has made a significant impact on medical procedures. His innovative patents and collaborations reflect his commitment to advancing healthcare technology.